Evotec SE/ DE0005664809 /
2024-11-08 1:10:29 PM | Chg. +0.08 | Volume | Bid2024-11-08 | Ask2024-11-08 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.07EUR | +1.00% | 106,980 Turnover: 351,980.34 |
8.07Bid Size: 530 | 8.09Ask Size: 251 | 1.41 bill.EUR | - | - |
GlobeNewswire
01-16
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and ...
GlobeNewswire
2023-12-11
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire
2023-11-07
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire
2021-10-11
Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement
GlobeNewswire
2021-04-26
Proactive news headlines including Chase Mining Corporation, Red River Resources, Aurumin and Kazia ...
GlobeNewswire
2021-04-20
Proactive news headlines including Queensland Pacific Metals, Moho Resources, Kazia Therapeutics and...
GlobeNewswire
2021-03-01
Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Preci...
GlobeNewswire
2020-06-04
Toronto Innovation Acceleration Partners Expands its LAB150 Portfolio with a Novel Cancer Therapeut...
GlobeNewswire
2019-12-12
Toronto Innovation Acceleration Partners (TIAP) adds novel KRAS oncology project to its LAB150 portf...
GlobeNewswire
2019-06-11
Mental Health is Focus of New High-Potential Anti-Depression Project from MaRS Innovation and the Ce...
GlobeNewswire
2018-02-15
EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire
2018-01-08
APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire
2017-09-14
MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire
2011-11-29
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
2011-10-27
Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi